Digital Nomad Entrepreneurship and Lifestyle Design: A Process Theory

Advances in information technology have led to the emergence of a digital workforce comprised of several types of workers, one such being the digital nomad. There is an opportunity in to expand the IS literature by investigating the entrepreneurial side of digital nomadism. Digital nomad entrepreneurship (DNE) is a growing phenomenon and distinctive approach to life and entrepreneurship. Previous research has tended to focus on either the lifestyle or business-level aspects of DNE. This study uses grounded theory method to investigate the merger of lifestyle and business factors that combine to form how an individual becomes a digital nomad entrepreneur. The findings reveal a model called the “Digital Nomad Entrepreneurship & Lifestyle Design Process”, which is comprised of four conceptual sub-categories: 1). Pre-Day Zero - Lamentation & Discovery, 2). Plugging In - Transition & Acculturation, 3). Just Get Started - 1,000 Messy Days, and 4). The Other Side - Mentality Shifts and Scale Lessons

Large-amplitude electric fields in the inner magnetosphere: Van Allen Probes observations of subauroral polarization streams

The subauroral polarization stream (SAPS) is an important magnetosphere-ionosphere (MI) coupling phenomenon that impacts a range of particle populations in the inner magnetosphere. SAPS studies often emphasize ionospheric signatures of fast westward flows, but the equatorial magnetosphere is also affected through strong radial electric fields in the dusk sector. This study focuses on a period of steady southward interplanetary magnetic field (IMF) during the 29 June 2013 geomagnetic storm where the Van Allen Probes observe a region of intense electric fields near the plasmapause over multiple consecutive outbound duskside passes. We show that the large-amplitude electric fields near the equatorial plane are consistent with SAPS by investigating the relationship between plasma sheet ion and electron boundaries, associated field-aligned currents, and the spatial location of the electric fields. By incorporating high-inclination DMSP data we demonstrate the spatial and temporal variability of the SAPS region, and we suggest that discrete, earthward propagating injections are driving the observed strong electric fields at low L shells in the equatorial magnetosphere. We also show the relationship between SAPS and plasmasphere erosion, as well as a possible correlation with flux enhancements for 100s keV electrons

Launching PCORnet, a national patient-centered clinical research network

The Patient-Centered Outcomes Research Institute (PCORI) has launched PCORnet, a major initiative to support an effective, sustainable national research infrastructure that will advance the use of electronic health data in comparative effectiveness research (CER) and other types of research. In December 2013, PCORI's board of governors funded 11 clinical data research networks (CDRNs) and 18 patient-powered research networks (PPRNs) for a period of 18 months. CDRNs are based on the electronic health records and other electronic sources of very large populations receiving healthcare within integrated or networked delivery systems. PPRNs are built primarily by communities of motivated patients, forming partnerships with researchers. These patients intend to participate in clinical research, by generating questions, sharing data, volunteering for interventional trials, and interpreting and disseminating results. Rapidly building a new national resource to facilitate a large-scale, patient-centered CER is associated with a number of technical, regulatory, and organizational challenges, which are described here

Correction: Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target

Correction: Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Targe

738–2 The Evolution of Therapy for Single Vessel Disease: A Treatment Comparison of Medicine, Angioplasty and Left Internal Mammary Artery Graft for Proximal Left Anterior Descending Disease

Saphenous vein bypass grafting for single vessel disease offers no survival or symptom relief advantage compared to medical therapy. Recent evidence suggests the use of the internal mammary artery or PTCA may be more beneficial than medicine. To examine the outcome of these treatment strategies, a retrospective analysis of prospectively collected data on 23,018 consecutive patients undergoing cardiac catheterization between April 1986 and February 1994 was performed. Of the 6,432 patients with single vessel disease, 1,222 had a proximal left anterior descending (LAD) stenosis>74% and no prior PTCA or CABG. A total of 289 were managed medically, 760 underwent PTCA, and 172 received a left internal mammary artery (LIMA) graft.Baseline demographic data and risk factor profiles were similar except for a higher incidence of diabetes (19 vs 15 vs 11%), history of MI (72 vs 58 vs 48%) CHF (18 vs 7 vs 8%), and total occlusions (44 vs 17 vs 7%) and lower incidence of unstable angina (40 vs 61 vs 64%) in the medical group as compared to PTCA and LIMA graft, respectively.Kaplan-Meier 6-year estimates:EventsMedicinePTCALIMAP-value–unadjusted survival (%)7885910.001–adjusted survival (%)8486900.24–event-free survival (%)5443720.0001ConclusionThere is a trend towards improved long-term survival in proximal LAD disease with a strategy of revascularization, particularly the LIMA graft. Furthermore, event-free survival is significantly improved with the LIMA graft as compared to medical therapy or PTCA

Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target

Using both genetic and biochemical approaches, David Williams and colleagues show that the parasite thioredoxin glutathione reductase meets all the major criteria to be a key target for antischistosomal chemotherapy

Evidence for Prevention of Death and Myocardial Infarction With Platelet Membrane Glycoprotein IIb/IIIa Receptor Blockade by Abciximab (c7E3 Fab) Among Patients With Unstable Angina Undergoing Percutaneous Coronary Revascularization fn1fn1This study was supported by Centocor, Inc., Malvern, Pennsylvania.

AbstractObjectives. We sought to evaluate whether patients with unstable angina undergoing coronary intervention derive particular clinical benefit from potent platelet inhibition.Background. Plaque rupture and platelet aggregation are pathogenetic processes common to unstable angina and ischemic complications of percutaneous coronary intervention.Methods. Of the 2,099 patients undergoing a coronary intervention in the Evaluation of 7E3 in Preventing Ischemic Complications (EPIC) trial, 489 were enrolled with the diagnosis of unstable angina and randomized to receive placebo, an abciximab (c7E3) bolus immediately before the intervention or an abciximab bolus followed by a 12-h infusion. The primary end point was a composite of death, myocardial infarction (MI) or urgent repeat revascularization within 30 days of randomization. The occurrence of death, MI or any revascularization within 6 months was also assessed.Results. Compared with placebo, the bolus and infusion of abciximab resulted in a 62% reduction in the rate of the primary end point (12.8% vs. 4.8%, p = 0.012) among patients with unstable angina, due primarily to a reduction in the incidences of death (3.2% vs. 1.2%, p = 0.164) and MI (9% vs. 1.8%, p = 0.004). By 6 months, cumulative death and MI were further reduced by abciximab (6.6% vs. 1.8%, p = 0.018 and 11.1% vs. 2.4%, p = 0.002, respectively). The magnitude of the risk reduction with abciximab was greater among the patients with unstable angina than among other patients in the EPIC trial without unstable angina for the end points of death (interaction: p = 0.008 at 30 days, p = 0.002 at 6 months) and MI (interaction: p = 0.004 at 30 days, p = 0.003 at 6 months).Conclusions. The syndrome of unstable angina identifies patients who will experience particularly marked reductions in the risk of death and MI with abciximab during coronary intervention.(J Am Coll Cardiol 1997;30:149–56

Abrupt closure: The CAVEAT I experience

Objectives.This study sought to assess the incidence and consequences of abrupt closure in a series of patients undergoing directional coronary atherectomy versus percutaneous coronary angioplasty.Background.Abrupt closure with coronary angioplasty has been associated with adverse outcome. The results from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT) I, a randomized trial of coronary angioplasty versus directional coronary atherectomy, were analyzed.Method.This multicenter trial enrolled 1,012 patients from 1991 to 1992. All records from patients with abrupt closure, which was coded as a discrete complication, were reviewed.Results.Abrupt closure occurred in 60 patients (5.9%) and was associated with a significantly longer hospital stay (median 8 vs. 3 days). Severe proximal target vessel tortuosity was more common in patients with abrupt closure (20.3% vs. 11.6%, p = 0.046), as was preexistent coronary artery thrombus (30.5% vs. 18.3%, p = 0.02). Abrupt closure was associated with a marked increase in subsequent complications (myocardial infarction 46.7% vs. 2.1%, emergency bypass surgery 383% vs. 0.32%, death 33% vs. 0%) and occurred more frequently in the directional coronary atherectomy group (8.0% vs. 3.8%, p = 0.005). In the coronary angioplasty group, the occlusion usually occurred at the target lesion (91%), presumably related to the effects of barotrauma. In the directional coronary atherectomy group, the site of the occlusion was the target lesion in only 58% (p = 0.045). The remaining occlusions related to problems with the technique (guide catheter or nose cone trauma), reflecting the fact that directional coronary atherectomy is a more complex procedure.Conclusions.Abrupt closure remains the principal determinant of adverse outcome after percutaneous procedures for the treatment of coronary artery disease. Although abrupt closure is more common with directional atherectomy than angioplasty, the sequelae are similar

790-2 Baseline Electrocardiogram Predicts 30-day Mortality Among 32,812 Patients with Acute Myocardial Infarction Treated with Thrombolysis

To determine the initial electrocardiographic variables predictive of survival among patients with acute myocardial infarction, we analyzed the baseline 12-lead ECGs in 32,812 patients enrolled into the GUSTO trial. All patients had≥0.1mV of ST segment elevation in at least one lead and received thrombolytic therapy. Those with LBBB or ventricular rhythm were excluded from analysis. Clinical follow-up was > 99.5% complete. 2218 (6.8%) patients died within 30 days of the initial ECG. Death within 30 days was more common in patients with RBBB (17%), LAFB (14%), and LPFB (17%), than in those with a normal conduction pattern (6%). Patients with ECG evidence of previous MI in a location distinct from the acute MI had a higher risk of death (9.8% vs. 5.9%) than those without prior infarction (p<0.0001). The variable having the greatest univariate predictive power for 30-day survival was the sum of the absolute ST-segment deviation in each lead (x2=341), as shown in the following mortality curve.Other ST segment variables that predicted 30-day survival were the sum of ST-segment elevation in each lead (x2=287). the maximum ST elevation in anyone lead (X2=257), and the number of leads with ST elevation (x2=250). When multivariate modeling was performed the sum of the absolute ST deviations, number of leads with ST elevation, prior ECG MI, RBBB, and LAFB each added independent prognostic information.We conclude that an ECG at the time of presentation contains substantial prognostic information which can be used to help stratify risk among thrombelytic-treated patients with acute myocardial infarction

THEMIS measurements of quasi‐static electric fields in the inner magnetosphere

We use 4 years of Time History of Events and Macroscale Interactions during Substorms (THEMIS) double‐probe measurements to offer, for the first time, a complete picture of the dawn‐dusk electric field covering all local times and radial distances in the inner magnetosphere based on in situ equatorial observations. This study is motivated by the results from the CRRES mission, which revealed a local maximum in the electric field developing near Earth during storm times, rather than the expected enhancement at higher L shells that is shielded near Earth as suggested by the Volland‐Stern model. The CRRES observations were limited to the duskside, while THEMIS provides complete local time coverage. We show strong agreement with the CRRES results on the duskside, with a local maximum near L = 4 for moderate levels of geomagnetic activity and evidence of strong electric fields inside L = 3 during the most active times. The extensive data set from THEMIS also confirms the day/night asymmetry on the duskside, where the enhancement is closest to Earth in the dusk‐midnight sector, and is farther away closer to noon. A similar, but smaller in magnitude, local maximum is observed on the dawnside near L = 4. The noon sector shows the smallest average electric fields, and for more active times, the enhancement develops near L = 7 rather than L = 4. We also investigate the impact of the uncertain boom‐shorting factor on the results and show that while the absolute magnitude of the electric field may be underestimated, the trends with geomagnetic activity remain intact.Key PointsWe show full local time coverage of the equatorial electric field from THEMISLocal maximum occurs near L = 4 during active times in dawn and dusk sectorsNo clear increased electric field with Kp near midnight at high LPeer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/110619/1/jgra51411.pd